These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37452694)

  • 1. Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining.
    Moir J; Aggarwal S; Skondra D
    Exp Biol Med (Maywood); 2023 May; 248(9):798-810. PubMed ID: 37452694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Drugs for Treatment of Age-Related Macular Degeneration.
    Francisco SG; Rowan S
    Adv Exp Med Biol; 2023; 1415():73-77. PubMed ID: 37440017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.
    Brilliant MH; Vaziri K; Connor TB; Schwartz SG; Carroll JJ; McCarty CA; Schrodi SJ; Hebbring SJ; Kishor KS; Flynn HW; Moshfeghi AA; Moshfeghi DM; Fini ME; McKay BS
    Am J Med; 2016 Mar; 129(3):292-8. PubMed ID: 26524704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2015 Feb; 2(2):CD006927. PubMed ID: 25675254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD006927. PubMed ID: 27490232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration.
    Lee H; Jeon HL; Park SJ; Shin JY
    Yonsei Med J; 2019 Jul; 60(7):679-686. PubMed ID: 31250582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of statins as a form of protection against age-related macular degeneration (AMD)].
    Drobek-Słowik M; Karczewicz D; Safranow K; Jakubowska K; Chlubek D
    Klin Oczna; 2008; 110(1-3):50-4. PubMed ID: 18669084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD006927. PubMed ID: 22419318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
    Maguire MG; Ying GS; McCannel CA; Liu C; Dai Y;
    Ophthalmology; 2009 Dec; 116(12):2381-5. PubMed ID: 19850347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006927. PubMed ID: 19588411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration.
    Wang SV; Kulldorff M; Poor S; Rice DS; Banks A; Li N; Lii J; Gagne JJ
    Ophthalmology; 2021 Feb; 128(2):248-255. PubMed ID: 32777229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).
    Guymer RH; Dimitrov PN; Varsamidis M; Lim LL; Baird PN; Vingrys AJ; Robman L
    Clin Interv Aging; 2008; 3(3):581-93. PubMed ID: 18982929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Question of a Role for Statins in Age-Related Macular Degeneration.
    Roizenblatt M; Naranjit N; Maia M; Gehlbach PL
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statins on the age of onset of age-related macular degeneration.
    Ganesh D; Chiang JN; Corradetti G; Zaitlen N; Halperin E; Sadda SR
    Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2245-2255. PubMed ID: 36917316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.
    Guymer RH; Baird PN; Varsamidis M; Busija L; Dimitrov PN; Aung KZ; Makeyeva GA; Richardson AJ; Lim L; Robman LD
    PLoS One; 2013; 8(12):e83759. PubMed ID: 24391822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do statins have a role in the prevention of age-related macular degeneration?
    Tsao SW; Fong DS
    Drugs Aging; 2013 Apr; 30(4):205-13. PubMed ID: 23423861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case control study of age related macular degeneration and use of statins.
    Smeeth L; Cook C; Chakravarthy U; Hubbard R; Fletcher AE
    Br J Ophthalmol; 2005 Sep; 89(9):1171-5. PubMed ID: 16113375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
    Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.